Literature DB >> 12624150

RNASEL mutations in hereditary prostate cancer.

H Chen, A R Griffin, Y-Q Wu, L P Tomsho, K A Zuhlke, E M Lange, S B Gruber, K A Cooney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12624150      PMCID： PMC1735394          DOI： 10.1136/jmg.40.3.e21

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  6 in total

1.  Identification of a prostate cancer susceptibility locus on chromosome 7q11-21 in Jewish families.

Authors:  Danielle M Friedrichsen; Janet L Stanford; Sarah D Isaacs; Marta Janer; Bao-Li Chang; Kerry Deutsch; Elizabeth Gillanders; Suzanne Kolb; Katherine E Wiley; Michael D Badzioch; S Lilly Zheng; Patrick C Walsh; Gail P Jarvik; Leroy Hood; Jeffrey M Trent; William B Isaacs; Elaine A Ostrander; Jianfeng Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

2.  Contribution of HPC1 (RNASEL) and HPCX variants to prostate cancer in a founder population.

Authors:  Ilir Agalliu; Suzanne M Leanza; Lorie Smith; Jeffrey M Trent; John D Carpten; Joan E Bailey-Wilson; Robert D Burk
Journal:  Prostate       Date:  2010-11-01       Impact factor: 4.104

3.  Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene.

Authors:  C Maier; J Haeusler; K Herkommer; Z Vesovic; J Hoegel; W Vogel; T Paiss
Journal:  Br J Cancer       Date:  2005-03-28       Impact factor: 7.640

4.  The clinical genetics of prostate cancer.

Authors:  Sashi Kommu; Stephen Edwards; Rosalind Eeles
Journal:  Hered Cancer Clin Pract       Date:  2004-07-15       Impact factor: 2.857

Review 5.  Epidemiology of Prostate Cancer.

Authors:  Prashanth Rawla
Journal:  World J Oncol       Date:  2019-04-20

6.  Hereditary prostate cancer in African American families: linkage analysis using markers that map to five candidate susceptibility loci.

Authors:  W M Brown; E M Lange; H Chen; S L Zheng; B Chang; K E Wiley; S D Isaacs; P C Walsh; W B Isaacs; J Xu; K A Cooney
Journal:  Br J Cancer       Date:  2004-01-26       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.